Date published: 2025-10-30

1-800-457-3801

SCBT Portrait Logo
Seach Input

LOC728392 Inhibitors

The chemical class denoted as LOC728392 Inhibitors is distinguished by its specific interaction with a biomolecule identified as LOC728392. Although the precise function and role of LOC728392 in cellular processes remain not fully elucidated, the inhibitors developed for this class are strategically designed molecules aimed at modulating the activity or function of LOC728392, thereby exhibiting an inhibitory effect. Researchers investigating LOC728392 Inhibitors employ an integrative approach, combining structural biology, medicinal chemistry, and computational techniques to unravel the intricate details of the molecular interactions between the inhibitors and LOC728392, shedding light on the potential impact of these compounds on cellular pathways.

Structurally, LOC728392 Inhibitors are meticulously crafted compounds with distinct molecular features tailored to facilitate selective binding to LOC728392. This specificity is crucial to minimize unintended effects on other cellular components, ensuring a targeted and focused impact. The development of inhibitors within this chemical class involves the optimization of pharmacokinetic properties and exploration of structure-activity relationships, as scientists aim to refine the molecular design for enhanced efficacy. As our understanding of LOC728392 Inhibitors advances, the insights gained contribute to a broader comprehension of cellular regulatory mechanisms and the potential roles of LOC728392 in various biological contexts. The exploration of LOC728392 Inhibitors thus represents a significant avenue for expanding fundamental knowledge in cellular biology and molecular pharmacology.

SEE ALSO...

Items 1 to 10 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Actinomycin D

50-76-0sc-200906
sc-200906A
sc-200906B
sc-200906C
sc-200906D
5 mg
25 mg
100 mg
1 g
10 g
$73.00
$238.00
$717.00
$2522.00
$21420.00
53
(3)

Actinomycin D intercalates into DNA, inhibiting transcription initiation and elongation, which could reduce LOC728392 expression.

α-Amanitin

23109-05-9sc-202440
sc-202440A
1 mg
5 mg
$260.00
$1029.00
26
(2)

α-Amanitin inhibits RNA polymerase II, which is responsible for mRNA synthesis, potentially decreasing LOC728392 expression.

Triptolide

38748-32-2sc-200122
sc-200122A
1 mg
5 mg
$88.00
$200.00
13
(1)

Triptolide has been shown to inhibit the transcription of various genes, which may include LOC728392.

DRB

53-85-0sc-200581
sc-200581A
sc-200581B
sc-200581C
10 mg
50 mg
100 mg
250 mg
$42.00
$185.00
$310.00
$650.00
6
(1)

DRB inhibits RNA polymerase II transcription elongation, potentially reducing LOC728392 expression.

Flavopiridol Hydrochloride

131740-09-5sc-207687
10 mg
$311.00
(2)

Flavopiridol inhibits cyclin-dependent kinases, which are necessary for RNA polymerase II-based transcription.

Cordycepin

73-03-0sc-203902
10 mg
$99.00
5
(1)

Cordycepin, an adenosine analog, can terminate RNA chain elongation, possibly affecting LOC728392 expression.

Trichostatin A

58880-19-6sc-3511
sc-3511A
sc-3511B
sc-3511C
sc-3511D
1 mg
5 mg
10 mg
25 mg
50 mg
$149.00
$470.00
$620.00
$1199.00
$2090.00
33
(3)

Trichostatin A inhibits histone deacetylase, affecting chromatin structure and possibly decreasing gene expression, including LOC728392.

Leptomycin B

87081-35-4sc-358688
sc-358688A
sc-358688B
50 µg
500 µg
2.5 mg
$105.00
$408.00
$1224.00
35
(2)

Leptomycin B inhibits nuclear export of mRNA, which could indirectly reduce expression of genes like LOC728392.

(±)-JQ1

1268524-69-1sc-472932
sc-472932A
5 mg
25 mg
$226.00
$846.00
1
(0)

JQ1 inhibits BET bromodomain proteins, which may downregulate expression of certain genes, possibly including LOC728392.

Mithramycin A

18378-89-7sc-200909
1 mg
$54.00
6
(1)

Mithramycin binds to GC-rich DNA sequences, inhibiting transcription and potentially affecting LOC728392 expression.